In hepatocellular carcinoma (HCC), multiple mutations and dysregulated signaling pathways, including WNT, MAPK, mTOR, TGF-β, STAT, and TERT, drive tumor initiation and progression. The gene discussed is SOAT1; the disease is hepatocellular carcinoma.